Search results (3949)
« Back to PublicationsWhat have we learnt from the inhibition of IL-6 in RA and what are the clinical opportunities for patient outcomes?
Journal article
Taylor PC. et al, (2024), Therapeutic advances in musculoskeletal disease
Development of a patient-centred tool for use in total hip arthroplasty
Journal article
Lubbeke A. et al, (2024), Plos one
Prevalence of complications in older adults after hip fracture surgery: a systematic review and meta-analysis
Journal article
Goh E. et al, (2024), Bone and joint journal
Efficacy and safety of filgotinib in patients with moderately active rheumatoid arthritis and an inadequate response to methotrexate
Journal article
Buch MH. et al, (2024), Rheumatology
Sustained response to guselkumab regardless of baseline characteristics in patients with active psoriatic arthritis and inadequate response to TNF inhibitors: results from the phase 3b COSMOS clinical trial
Journal article
McInnes IB. et al, (2024), Rmd open
The management of acute complete ruptures of the ulnar collateral ligament of the thumb.
Journal article
Mikhail M. et al, (2024), Bone jt open, 5, 708 - 714
Recurrent patellar dislocation: personalised therapy or operative treatment? The REPPORT randomised trial protocol.
Journal article
Arnold S. et al, (2024), Bmj open, 14
Impact of high rheumatoid factor levels on treatment outcomes with certolizumab pegol and adalimumab in patients with rheumatoid arthritis
Journal article
Smolen JS. et al, (2024), Rheumatology
Inflammatory disease status and response to TNF blockade are associated with mechanisms of endotoxin tolerance.
Journal article
Clanchy FI. et al, (2024), J autoimmun, 148
Digital endpoints in clinical trials: emerging themes from a multi-stakeholder Knowledge Exchange event
Journal article
Tackney MS. et al, (2024), Trials, 25
Breakout Session and Report Back: Collaboration of Rheumatologists and Dermatologists for the Care of Patients With Psoriatic Disease.
Journal article
Kampel Stolnicki D. et al, (2024), J rheumatol
Five-year outcomes for patients sustaining severe fractures of the lower limb from the Wound Healing in Surgery for Trauma (WHIST) trial.
Journal article
Costa ML. et al, (2024), Bone joint j, 106-B, 858 - 864
Risk of serious adverse events after primary shoulder replacement: development and external validation of a prediction model using linked national data from England and Denmark.
Journal article
Valsamis EM. et al, (2024), Lancet rheumatol
Safety and efficacy of bimekizumab in patients with psoriatic arthritis: 2-year results from two phase 3 studies
Journal article
Mease PJ. et al, (2024), Rheumatology and therapy
Treatment of early oligoarticular psoriatic arthritis with apremilast: primary outcomes at week 16 from the FOREMOST randomised controlled trial
Journal article
Gossec L. et al, (2024), Annals of the rheumatic diseases
Streamlining electronic reporting of serious adverse events (SAEs) using the REDCap data collection system: the eSAE Project
Journal article
Black J. et al, (2024), Trials
Lumbar spine fusion surgery versus best conservative care for patients with severe, persistent low back pain.
Journal article
Bada ES. et al, (2024), Bone jt open, 5, 612 - 620
Development of an intervention for patients following an anterior cruciate ligament rupture: an online nominal group technique consensus study.
Journal article
Carter H. et al, (2024), Bmj open, 14
A real-world comparison of clinical effectiveness in patients with rheumatoid arthritis treated with upadacitinib, tumor necrosis factor inhibitors, and other advanced therapies after switching from an initial tumor necrosis factor inhibitor
Journal article
Caporali R. et al, (2024), Advances in therapy
Exploring TNFi drug-levels and anti-drug antibodies during tapering among patients with inflammatory arthritis: secondary analyses from the randomised BIODOPT trial
Journal article
Uhrenholt L. et al, (2024), Rheumatology international